A detailed history of Ameritas Investment Partners, Inc. transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 8,867 shares of LXRX stock, worth $6,738. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,867
Previous 8,867 -0.0%
Holding current value
$6,738
Previous $14,000 7.14%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$1.3 - $3.58 $4,550 - $12,530
3,500 Added 65.21%
8,867 $21,000
Q2 2021

Aug 06, 2021

BUY
$4.12 - $5.87 $6,530 - $9,303
1,585 Added 41.91%
5,367 $25,000
Q2 2017

Aug 15, 2017

BUY
N/A
3,782
3,782 $62,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $143M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.